García-Campos JA, Guzmán-de la Garza FJ, Alejandro-Quiroga VM, González-Ruiz MC, Moreno-Sánchez H, Cámara-Lemarroy CR

Language: Spanish
References: 27
Page: 359-363
PDF size: 156.80 Kb.

ABSTRACT

Background. Dengue fever is an infectious disease caused by a flavivirus and transmitted by a vector. It causes dengue fever, dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS). When one of these last two appears, treatment consists of intensive fluid balance control.
Case report. A 4-month-old female infant presented fever. She was admitted and later showed signs and symptoms of DHF followed by DSS. Serological diagnosis was confirmed, and appropriate treatment offered. The mother does not have evidence of prior infection.
Discussion. One theory proposes that DHF occurs in infants when passively transferred maternal antibodies from a previous infection cause an enhanced immune response when the infant is infected by a different type of dengue virus. This theory does not explain the occurrence of DHF in our report. Factors not dependent on the host, such as virological factors, may be responsible.

REFERENCES

1. Clyde K, Kyle JL, Harris E. Recent advances in deciphering viral and host determinants of dengue virus replication and pathogenesis. J Virol 2006;80:11418-11431.

2. Manual para la Vigilancia Diagnóstico, Prevención y Control del Dengue. Instituto Nacional de Diagnóstico y Referencia Epidemiológica. INDRE, SSA, 2007.

3. World Health Organization. Prevention and control of dengue and dengue haemorrhagic fever: comprehensive guidelines. WHO Regional Publication, SEARO, No 29, 1999.

4. Panorama Epidemiológico del Dengue y Dengue Hemorrágico. Disponible en: www.cenave.gob.mx/dengue/Panorama/Panoramasemana492008.pdf

5. Vaughn DW, Green S, Kalayanarooj S, Innis BL, Nimmannitya S, Suntayakorn S, et al. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis 2000;181:2-9.

6. Díaz A, Kourí G, Guzman MG, Lobaina L, Bravo J, Ruiz A. Cuadro clínico de la fiebre hemorrágica del dengue/síndrome de choque del dengue en adulto. Bol Oficina Sanit Panam 1988;104:560-571.

7. Enfermedades Tropicales en México. Diagnóstico, Tratamiento y Distribución Geográfica. Instituto Nacional de Diagnóstico y Referencia Epidemiológica. INDRE, SSA, 1994.

8. Kao CL, King CC, Chao DY, Wu HL, Chang GJ. Laboratory diagnosis of dengue virus infection: current and future perspectives in clinical diagnosis and public health. J Microbiol Immunol Infect 2005;38:5-16.

9. Singhi S, Kissoon N, Bansal A. Dengue and dengue hemorrhagic fever: management issues in an intensive care unit. J Pediatr (Rio J) 2007;83(suppl 2):S22-S35.

10. Choudhry SP, Gupta RK, Kishan J. Dengue shock syndrome in newborn: a case series. Indian Pediatr 2004;41:397-399.

11. Hammond SN, Balmaseda A, Pérez L, Tellez Y, Saborío SI, Mercado JC, et al. Differences in dengue severity in infants, children, and adults in a three-year hospital-based study in Nicaragua. Am J Trop Med Hyg 2005;73:1063-1070.

12. Halstead SB. Dengue. Lancet 2007;370:1644-1652.

13. Green S, Rothman A. Immunopathological mechanisms in dengue and dengue hemorrhagic fever. Curr Opin Infect Dis 2006;19:429-436.

14. Rothman AL. Dengue: defining protective versus pathologic immunity. J Clin Invest 2004;113:946-951.

15. Halsted SB, Lan NT, Myint TT, Shwe TN, Nisalak A, Kalyanarooj S, et al. Dengue hemorrhagic fever in infants: research opportunities ignored. Emerg Infect Dis 2002;8:1474-1479.

16. Malavige GN, Fernando S, Fernando DJ, Seneviratne SL. Dengue viral infections. Postgrad Med J 2004;80:588-601.

17. Kliks SC, Nimmannitya S, Nisalak A, Burke DS. Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants. Am J Trop Med Hyg 1988;38:411–419.

18. Mourão MP, Lacerda MV, Bastos Md Mde S, Albuquerque BC, Alecrim WD. Dengue hemorrhagic fever in infants: report of two cases. Rev Soc Bras Med Trop 2004;37:175-176.

19. Watts DM, Porter KR, Putvatana P, Vasquez B, Calampa C, Hayes CG, et al. Failure of secondary infection with American genotype dengue 2 to cause dengue haemorrhagic fever. Lancet 1999;354:1431-1434.

20. Rico-Hesse R. Dengue virus evolution and virulence models. Clin Infect Dis 2007;44:1462-1466.

21. Rosen L. Comments on the epidemiology, pathogenesis and control of dengue. Med Trop (Mars) 1999;59(4 Pt 2):495-498.

22. Wearing HJ, Rohani P. Ecological and immunological determinants of dengue epidemics. PNAS USA 2006;103:11802-11807.

23. Messer WB, Vitarana UT, Sivananthan K, ElvtigalaJ, Preethimala LD, Ramesh R, et al. Epidemiology of dengue in Sri Lanka before and after the emergence of epidemic dengue hemorrhagic fever. Am J Trop Med Hyg 2002;66:765–773.

24. Cologna R, Armstrong PM, Rico-Hesse R. Selection for virulent dengue viruses occurs in humans and mosquitoes. J Virol 2005;79:853-859.

25. Díaz FJ, Black WC 4th, Farfán-Ale JA, Loroño-Pino MA, Olson KE, Beaty BJ. Dengue virus circulation and evolution in Mexico: a phylogenetic perspective. Arch Med Res 2006;37:760-773.

26. Anderson JR, Rico-Hesse R. Aedes aegypti vectorial capacity is determined by the infecting genotype of dengue virus. Am J Trop Med Hyg 2006;75:886-892.

27. Ngo NT Cao XT, Kneen R, Willis B, Nguyen VM, Nguyen TQ, Chu VT, et al. Acute management of dengue shock syndrome: a randomized double blind comparison of four intravenous fluid regimens in the first hour. Clin Infect Dis 2001;32:204-213.